Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 91351-91400 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05002452
Observational Study of Factors Predicting Therapeutic Effects and Clinical Prognosis After HAIC for Locally Advanced HCC
N/A
Recruiting
150 participants
Started: Dec 20, 2021 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT06881329
Epigenome-wide DNA Methylation Profiling in Aneurysmal Subarachnoid Hemorrhage and Delayed Ischemic Neurologic Deficit
N/A
Active, not recruiting
61 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2025
4 conditions
2 sponsors
1 location
NCT05071963
INSPIRE Pipeline™ Shield Post Approval Study
N/A
Active, not recruiting
246 participants
Started: Dec 20, 2021 · Completed: Apr 30, 2028
1 condition
1 sponsor
16 locations
NCT05218395
Association Between Persistent Organic Pollutants and Type 2 Diabetes /Thyroid Cancer
N/A
Recruiting
900 participants
Started: Dec 20, 2021 · Completed: Dec 30, 2025
3 conditions
2 sponsors
1 location
NCT04921527
Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer
PHASE3
Recruiting
454 participants
Started: Dec 20, 2021 · Completed: Jul 31, 2025
4 conditions
1 sponsor
1 location
NCT05210803
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD
N/A
Enrolling by invitation
115 participants
Started: Dec 20, 2021 · Completed: Mar 31, 2028
6 conditions
1 sponsor
16 locations
NCT04770753
A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT)
PHASE3
Active, not recruiting
194 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2028
2 conditions
1 sponsor
68 locations
NCT04819100
A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)
PHASE3
Active, not recruiting
152 participants
Started: Dec 20, 2021 · Completed: May 31, 2028
1 condition
2 sponsors
211 locations
NCT06187337
Interceptive Maxillary Expansion to Relief Anterior Crowding in the Mixed Dentition
NA
Recruiting
60 participants
Started: Dec 20, 2021 · Completed: Jan 31, 2028
3 conditions
1 sponsor
4 locations
NCT05712824
V-Lap System For Wirelessly Measuring And Monitoring Left Atrial Pressure (LAP) In Patients With Advance CHF
NA
Recruiting
10 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2027
1 condition
1 sponsor
3 locations
NCT05474417
The Effects of the CF Carrier State on the Kidneys and Pancreas
N/A
Recruiting
1,250 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2025
3 conditions
3 sponsors
1 location
NCT05157386
Physical Exercise as Adjunctive Therapy for Affective Disorder and Anxiety
N/A
Active, not recruiting
50 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2025
14 conditions
2 sponsors
1 location
NCT05174351
Beta-blocker Discontinuation in Heart Failure With Preserved Ejection Fraction
NA
Recruiting
30 participants
Started: Dec 20, 2021 · Completed: Nov 1, 2027
1 condition
1 sponsor
1 location
NCT04842006
Systemic Neoadjuvant and Adjuvant Control by Precision Medicine in Rectal Cancer
NA
Recruiting
93 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2031
1 condition
1 sponsor
2 locations
NCT06191172
The Effect of Person-Centered Care Applied to Patients With Dementia on Nutritional Status
NA
Active, not recruiting
55 participants
Started: Dec 20, 2021 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT06121804
Immunosuppressants to Postoperative Infection and Death
N/A
Recruiting
20,000 participants
Started: Dec 20, 2021 · Completed: Dec 20, 2024
3 conditions
1 sponsor
1 location
NCT05162573
EBRT + Lu-PSMA for N1M0 Prostate Cancer
PHASE1
Recruiting
24 participants
Started: Dec 20, 2021 · Completed: Jul 1, 2025
1 condition
3 sponsors
2 locations
NCT04510636
Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma
PHASE2
Recruiting
37 participants
Started: Dec 20, 2021 · Completed: Jun 1, 2026
3 conditions
1 sponsor
1 location
NCT05474430
Estimating Risk of Respiratory Infections Attributable to CFTR Heterozygosity
N/A
Recruiting
160 participants
Started: Dec 20, 2021 · Completed: Jul 31, 2025
2 conditions
3 sponsors
1 location
NCT04974216
Study of Tafasitamab and Lenalinomide Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Older
PHASE2
Active, not recruiting
71 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
15 locations
NCT05264753
PMCF Study to Evaluate Efficacy, Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects
N/A
Recruiting
255 participants
Started: Dec 20, 2021 · Completed: Nov 25, 2026
1 condition
1 sponsor
8 locations
NCT04989894
Quality of Recovery After Childbirth
N/A
Recruiting
122 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT05060627
Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide
PHASE1/PHASE2
Recruiting
60 participants
Started: Dec 20, 2021 · Completed: May 30, 2028
1 condition
2 sponsors
15 locations
NCT05156203
Safety and Tolerability Study for T-1301 Capsules to Treat Advanced Solid Tumors
PHASE1
Recruiting
30 participants
Started: Dec 19, 2021 · Completed: Dec 31, 2027
2 conditions
1 sponsor
3 locations
NCT06764576
Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis
N/A
Recruiting
13,000 participants
Started: Dec 19, 2021 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05207254
Research on the Application of Artificial Intelligence Ultrasonic Recognition Technology in Difficult Airway Assessment
N/A
Recruiting
4,000 participants
Started: Dec 18, 2021 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05535621
68Ga-HER2 Affibody PET/CT Imaging for HER2-Positive Cancer Patients
N/A
Recruiting
100 participants
Started: Dec 18, 2021 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05095701
An Immunity Persistence Study of Live Attenuated Varicella Vaccine
PHASE4
Enrolling by invitation
703 participants
Started: Dec 18, 2021 · Completed: Oct 1, 2025
1 condition
1 sponsor
2 locations
NCT05252715
Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 5 Months
PHASE3
Active, not recruiting
1,200 participants
Started: Dec 18, 2021 · Completed: Sep 18, 2024
1 condition
1 sponsor
2 locations
NCT06773533
Registry of Adjuvant Hormone-blockade Breast Cancer Patients Evaluated for Bone Mineral Metabolism
N/A
Recruiting
3,000 participants
Started: Dec 18, 2021 · Completed: Dec 31, 2039
1 condition
1 sponsor
1 location
NCT05153889
Low Risk Non ST Elevation Myocardial Infarction With or Without Intensive Care Unit Admission
NA
Recruiting
320 participants
Started: Dec 18, 2021 · Completed: Jul 31, 2025
1 condition
1 sponsor
3 locations
NCT06575140
Associative Peripheral Stimulation for Reduction of Motor Impairment During Acute Period of Stroke Recovery
NA
Recruiting
20 participants
Started: Dec 18, 2021 · Completed: Dec 31, 2024
9 conditions
1 sponsor
3 locations
NCT04701437
Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants
NA
Recruiting
80 participants
Started: Dec 17, 2021 · Completed: Jun 30, 2026
1 condition
3 sponsors
1 location
NCT04463498
Sleep in Psychiatric Care (SIP): A Transdiagnostic Group-based Sleep-school as Treatment for Comorbid Insomnia
NA
Recruiting
60 participants
Started: Dec 17, 2021 · Completed: Dec 31, 2027
2 conditions
2 sponsors
1 location
NCT05007132
Trifluridine/ Tipiracil Plus Panitumumab Versus Trifluridine/ Tipiracil Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer
PHASE2
Recruiting
153 participants
Started: Dec 17, 2021 · Completed: Dec 31, 2032
1 condition
1 sponsor
1 location
NCT05192382
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)
PHASE3
Active, not recruiting
111 participants
Started: Dec 17, 2021 · Completed: Jan 31, 2028
1 condition
1 sponsor
57 locations
NCT05067283
A Study of MK-1084 in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
PHASE1
Recruiting
830 participants
Started: Dec 17, 2021 · Completed: Feb 25, 2030
1 condition
1 sponsor
71 locations
NCT04782713
Smart Prostate Specific Antigen (PSA) Screening Study
NA
Active, not recruiting
49 participants
Started: Dec 17, 2021 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05164341
Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PL
PHASE3
Active, not recruiting
69 participants
Started: Dec 17, 2021 · Completed: Oct 31, 2026
1 condition
1 sponsor
31 locations
NCT06812806
Correlation Between the Change in the Antero-posterior Diameter of the Pelvic Side and the Incidence of Post-partum Urinary Incontinence
N/A
Recruiting
240 participants
Started: Dec 17, 2021 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT05041842
Treatment With Tucatinib in Patients With an Isolated Brain Progression of a Metastatic Breast Cancer
PHASE2
Active, not recruiting
53 participants
Started: Dec 17, 2021 · Completed: Apr 30, 2026
1 condition
3 sponsors
15 locations
NCT05207046
The ACCESSIT Study
N/A
Recruiting
30 participants
Started: Dec 17, 2021 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05096923
UNC Childhood, Adolescent, and Young Adult Cancer Cohort
N/A
Recruiting
500 participants
Started: Dec 17, 2021 · Completed: Dec 31, 2031
4 conditions
2 sponsors
1 location
NCT05423977
Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors
PHASE1
Enrolling by invitation
36 participants
Started: Dec 17, 2021 · Completed: Jul 7, 2026
1 condition
1 sponsor
1 location
NCT04500847
Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD
PHASE1
Recruiting
35 participants
Started: Dec 17, 2021 · Completed: Mar 31, 2026
3 conditions
5 sponsors
2 locations
NCT05305950
Barriers and Facilitators in Access to OT/PT in Pediatric Cancer Survivors
N/A
Active, not recruiting
60 participants
Started: Dec 17, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05525637
Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder
PHASE3
Recruiting
1,041 participants
Started: Dec 17, 2021 · Completed: Dec 31, 2024
1 condition
1 sponsor
88 locations
NCT05038735
Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.
PHASE3
Active, not recruiting
212 participants
Started: Dec 17, 2021 · Completed: Oct 15, 2026
1 condition
1 sponsor
68 locations
NCT05767385
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
PHASE2/PHASE3
Recruiting
150 participants
Started: Dec 17, 2021 · Completed: Dec 31, 2025
4 conditions
3 sponsors
5 locations
NCT04991467
A Multimodal Parent-focused Intervention for Vulnerable Populations in the Bronx
NA
Recruiting
360 participants
Started: Dec 17, 2021 · Completed: May 31, 2026
2 conditions
3 sponsors
1 location
Previous
1
More pages
1825
1826
1827
1828
1829
1830
1831
More pages
2369
Next